-
Other partners include Anne-Mari Paster, previously CFO of MPM Capital, a venture capital firm, and Nick Leschly, a biotech executive.
FORBES: Biotech Battle Scars
-
The partners at MPM are at the top of the game because they've been at it for so long.
FORBES: Splicing For Dollars
-
Now all eyes are on MPM (stands for Medical Portfolio Management)and what it decides to do with so much money.
FORBES: Splicing for Dollars
-
Dennis Henner joined MPM as a partner in 2001, after 20 years at Genentech, where he served as head of re-search.
FORBES: Magazine Article
-
Now all eyes are on MPM (stands for Medical Portfolio Management) and what it decides to do with so much money.
FORBES: Splicing For Dollars
-
Dennis Henner joined MPM as a partner in 2001, after 20 years at Genentech, where he served as head of research.
FORBES: Magazine Article
-
The big dollars have enabled MPM to invest in nontraditional ways, too.
FORBES: Companies, People, Ideas
-
Peter, managing director at MPM Capital, invited WCC to invest in Aratana alongside his firm and another VC firm, Avalon.
FORBES: Changing the Face of Angel Investing
-
CHF's investors include MPM Capital, Investor Growth Capital and SV Life Sciences.
FORBES: Magazine Article
-
Von Emster invests alongside the MPM venture team and has access to MPM's 9 analysts, 16 other partners and 17 advisory board members, throwing a lot of brainpower behind each buy or sell.
FORBES: Companies & Strategies
-
So despite having a drug in front of the FDA, AVEO is currently a negative return for its venture investors (the ones who have held large portions to date) or at most a marginal win (1.3x) for those that exited in 2011 (looks like Flagship has exited, whereas MPM, Highland have been holding at least some of their positions).
FORBES: Biotech's Capital Intensity Challenge: A Post-Mortem on 2007's Biggest Deals